FIELD: medicine.
SUBSTANCE: evaluating a risk of atrophic gastritis in Khakassia Caucasians is ensured by measuring the IL-2 concentration, the PHA-induced IL-8 production, and the phagocytic neutrophil count. The established risk factors are graded (A1-A3) and evaluated; prognostic coefficients P1 and P2 are determined by formulas: P1 = -94.6+0.27·A1+1.25·A2-0.28·A3, P2 = -63.4+0.09·A1+0.56·A2-0.18·A3, wherein A1 is the IL-2 concentration; A2 is the phagocytic neutrophil count; A3 is the PHA-stimulated IL-8 production. If P1>P2, the low risk is predicted, whereas P1<P2 shows the high risk of atrophic gastritis in Khakassia Caucasians.
EFFECT: using the given method enables evaluating the risk of atrophic gastritis in Khakassia Caucasians and increasing the diagnostic effectiveness in atrophic gastritis.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR HELICOBACTER PYLORI-ASSOCIATED CHRONIC GASTRITIS RISK ASSESSMENT BASED ON SPECIFIC IMMUNOLOGICAL PARAMETERS IN KHAKASSIA CAUCASIANS | 2015 |
|
RU2614851C1 |
| METHOD FOR EVALUATING RISK OF DUODENAL ULCER IN KHAKASS BY GENETIC ANALYSIS | 2014 |
|
RU2563828C1 |
| EARLY DIAGNOSTIC TECHNIQUE FOR DUODENAL ULCER IN KHAKASS CAUCASIANS BY MOLECULAR GENETIC TESTING | 2013 |
|
RU2542459C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING COMPLICATED GASTRIC ULCER BASED ON DETERMINING EXPRESSION LEVEL OF MICRORNA-146A | 2024 |
|
RU2823474C1 |
| METHODS AND PRODUCTS FOR DIAGNOSTICS OF AUTOIMMUNE DISEASES AND GASTRIC CANCER, ASSOCIATED WITH ATROPHIC GASTRITIS | 2008 |
|
RU2519646C2 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF ECZEMA IN PATIENTS SUFFERING ACCOMPANIED CHRONIC GASTRODUODENITIS | 2011 |
|
RU2461836C1 |
| METHOD FOR PREDICTING EARLY DEVELOPMENT OF DUODENAL ULCER | 2016 |
|
RU2652275C2 |
| METHOD OF ASSESSING THE PROBABILITY OF ATROPHIC GASTRITIS IN PATIENTS WITH CHRONIC CORONARY HEART DISEASE | 2022 |
|
RU2806066C2 |
| METHOD FOR TREATING THE CASES OF CHRONIC ATROPHIC GASTRITIS | 2002 |
|
RU2219940C1 |
| METHOD FOR DIFFERENTIATION BETWEEN THE RISK IN DEVELOPING GASTRIC ULCER AND DUODENAL ULCER | 2000 |
|
RU2225615C2 |
